SATIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Dec 2025)
What this means for you
This application is over — abandoned 01 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97512123
- Mark type
- Stylized text
- Filed
- 20 Jul 2022
- Published for opposition
- 05 Sept 2023
- Abandoned
- 01 Dec 2025
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Vaccines, namely, dermal patches featuring vaccines; pharmaceutical preparations for the prevention and treatment of infectious diseases and non-infectious diseases, namely, dermal patches featuring pharmaceutical preparations for the prevention and treatment of hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; medical diagnostic reagents and assays for testing of body fluids, namely, dermal patches featuring medical diagnostics or assays for testing of body fluids; reagents for use in medical genetic testing, namely, dermal patches featuring reagents for use in medical genetic testing
- Class 010 — Medical apparatus: Medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; genetic testing apparatus for medical purposes; dermal patches for delivery of pharmaceuticals and vaccines, sold empty; medical devices for obtaining body fluid samples; medical devices for testing body fluid samples; dermal patches for testing DNA and RNA samples; dermal patches for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, , immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; dermal patches for testing for genetic testing; dermal patches for obtaining body fluid samples; dermal patches for testing body fluid samples
Owner
- Satio, Inc., Boston, MA, US
- Satio, Inc., Boston, MA, US
Prosecution history
- 01 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2025 — SOU EXTENSION 3 GRANTED
- 03 Apr 2025 — SOU EXTENSION 3 FILED
- 03 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2024 — SOU EXTENSION 2 GRANTED
- 18 Sept 2024 — SOU EXTENSION 2 FILED
- 18 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Apr 2024 — SOU EXTENSION 1 GRANTED
- 26 Apr 2024 — SOU EXTENSION 1 FILED
- 26 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2023 — CORRECTED NOA E-MAILED